Skip to content

Baidaijing Capsules Combined with Metronidazole in the Treatment of Trichomonas Vaginitis

Baidaijing Capsules Combined with Metronidazole in the Treatment of Trichomonas Vaginitis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004155
Enrollment
Unknown
Registered
2020-09-28
Start date
2020-10-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trichomonas vaginitis

Interventions

Sponsors

First Affiliated Hospital, Heilongjiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Those aged between 18 and 55 years; (2) Those who meet both Chinese medicine diagnosis and western medicine diagnosis; (3) Simple trichomoniasis infection for the first time or trichomoniasis combined with other pathogens and mold infections; (4) The patient has not received any treatment since the onset of the disease; (5) Those who voluntarily participate in this experiment and have regular follow-up inspections.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the diagnostic criteria of Chinese and Western medicine; (2) Patients with other simple bacterial, viral, and fungal vaginitis; (3) Patients with pelvic inflammatory disease, severe cervical erosion, gynecological tumors, allergic constitution, and vital organ dysfunction; (4) During menstruation, pregnancy, lactation, vulvar and vaginal mucosa rupture, and leucorrhea. (5) Those who are unwilling to follow up.

Design outcomes

Primary

MeasureTime frame
Trichomonas;Fungus;

Secondary

MeasureTime frame
Quality of Life Evaluation Scale SF-36;TCM symptom score;

Countries

China

Contacts

Public ContactHan Fengjuan
hanfengjuan2004@163.com+86 13645067243

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026